Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OpGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
OpGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
OpGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
OpGen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
OpGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
OpGen Inc, Medical Equipment, Deal Details 12
Venture Financing 12
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 15
OpGen Raises US$2 Million In Venture Financing 16
AdvanDx Raises US$2 Million In Venture Financing 17
OpGen Raises Additional US$2.6 Million In Series C Financing 18
OpGen Secures An Additional US$3 Million In Series B Round Of Financing 20
Partnerships 22
OpGen Enters into Research Agreement with Merck 22
OpGen Enters into Co-Development Agreement with Fluidigm 23
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 24
OpGen Enters Into Co-Development Agreement With In-Q-Tel 25
Equity Offering 26
OpGen Plans to Raise Funds through Public Offering of Units 26
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 29
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 30
OpGen Raises USD17 Million in IPO 32
Debt Offering 34
OpGen Raises USD0.5 Million in Debt Financing 34
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 35
Acquisition 36
OpGen Acquires AdvanDx 36
OpGen Inc – Key Competitors 37
OpGen Inc – Key Employees 38
OpGen Inc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 40
Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 42
Apr 26, 2017: OpGen Announces 2017 First Quarter Financial Results 44
Mar 23, 2017: OpGen Announces 2016 Fourth Quarter and Year End Financial Results 45
Jan 26, 2017: OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results 47
Oct 24, 2016: OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update 49
Aug 09, 2016: OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update 50
May 12, 2016: OpGen Reports 2016 First Quarter Financial Results and Business Update 51
Mar 30, 2016: OpGen Announces 2015 Fourth Quarter and Full Year Financial Results 52
Corporate Communications 53
Apr 27, 2017: OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors 53
May 02, 2016: OpGen Appoints Harry J. D’Andrea to Board of Directors 54
Mar 21, 2016: OpGen Announces New Members to its Clinical Advisory Board 55
Government and Public Interest 56
May 04, 2016: OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities 56
Product News 57
Apr 12, 2017: OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 57
Feb 14, 2017: OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting 59
Oct 26, 2016: Opgen’s Infectious Disease Portfolio Highlighted At IDWeek 2016 60
Other Significant Developments 61
Jun 15, 2017: OpGen’s Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
OpGen Inc, Medical Equipment, Key Facts, 2016 2
OpGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
OpGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
OpGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
OpGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
OpGen Inc, Deals By Market, 2011 to YTD 2017 9
OpGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 15
OpGen Raises US$2 Million In Venture Financing 16
AdvanDx Raises US$2 Million In Venture Financing 17
OpGen Raises Additional US$2.6 Million In Series C Financing 18
OpGen Secures An Additional US$3 Million In Series B Round Of Financing 20
OpGen Enters into Research Agreement with Merck 22
OpGen Enters into Co-Development Agreement with Fluidigm 23
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 24
OpGen Enters Into Co-Development Agreement With In-Q-Tel 25
OpGen Plans to Raise Funds through Public Offering of Units 26
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 29
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 30
OpGen Raises USD17 Million in IPO 32
OpGen Raises USD0.5 Million in Debt Financing 34
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 35
OpGen Acquires AdvanDx 36
OpGen Inc, Key Competitors 37
OpGen Inc, Key Employees 38
OpGen Inc, Subsidiaries 39